For example, at 24 months, mean pain ratings on a 100-point scale had decreased 8 points ... assessments such as DAS28 for rheumatoid arthritis or WOMAC scores for OA that include objective ...
Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...
People who took semaglutide also reported about a 42-point drop on the pain scale, compared to a drop of 27.5 in the control ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback